Mellitus' Unattributed Round

Mellitus raised a round of funding on October 04, 2013.

Mellitus is developing a novel in vitro diagnostic test for the measurement of Glycated CD59 (GCD59) with potential clinical utility in screening, diagnosis and monitoring of diabetes, stratification …

Articles about Mellitus' Unattributed Round: